Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Epigenetic Reader Domain
    (13)
  • PROTACs
    (4)
  • Ligands for Target Protein for PROTAC
    (3)
  • E1/E2/E3 Enzyme
    (1)
  • Others
    (5)
Filter
Search Result
Results for "

brm/brg1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    24
    TargetMol | Inhibitors_Agonists
  • PROTAC Products
    13
    TargetMol | PROTAC
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
BRM/BRG1 ATP Inhibitor-1
T106162270879-17-7
BRM BRG1 ATP Inhibitor-1 is an allosteric dual Brahma homolog (BRM) SWI SNF related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2) and BRG1 SMARCA4 ATPase activity inhibitor (IC50s<0.005 μM).
  • Inquiry Price
Size
QTY
PROTAC BRM/BRG1 degrader-4
T200933
PROTAC BRM BRG1 degrader-4 (example 047) is a potent degrader targeting both BRM and BRG1, demonstrating DC50 values of 0.21 nM and 3.4 nM respectively in SW1573 cells.
  • Inquiry Price
Size
QTY
PROTAC BRM/BRG1 degrader-2
T2015092933124-32-2
PROTAC BRM BRG1 degrader-2 (Example.004) is a potent PROTAC BRM BRG1 degrading agent exhibiting a DC50 of less than 10 nM and an IC50 of 15 nM in A549 cells.
  • Inquiry Price
Size
QTY
BRM/BRG1 ligand 3
T2015972933126-51-1
BRM BRG1 ligand 3 is a target protein ligand utilized in the synthesis of PROTAC BRM BRG1 degrader-3.
  • Inquiry Price
Size
QTY
BRM/BRG1 ligand 1
T2016351893977-70-2
BRM BRG1 Ligand 1 is a BRM BRG1 ligand utilized for the synthesis of PROTAC BRM BRG1 degrader-1.
  • Inquiry Price
Size
QTY
PROTAC BRM/BRG1 degrader-1
T2016732724268-88-4
PROTAC BRM BRG1 degrader-1 is a chemical compound that acts as a degrader of PROTAC BRM BRG1, exhibiting a DC50 range of 10-100 nM (BRM) and > 1 μM (BRG1). This compound is utilized in cancer research.
  • Inquiry Price
Size
QTY
BRM/BRG1 ligand 2
T2017092933125-88-1
BRM BRG1 ligand 2 serves as a target protein ligand for the synthesis of PROTAC BRM BRG1 degrader-2.
  • Inquiry Price
Size
QTY
PROTAC BRM/BRG1 degrader-3
T2018322933125-05-2
PROTAC BRM BRG1 degrader-3 (compound 304) is a PROTAC-based degrader of BRM BRG1. In SW1573 cells, it degrades BRM with a DC50 of less than 1 nM and BRG1 with a DC50 greater than 1 nM. PROTAC BRM BRG1 degrader-3 exhibits antitumor activity and inhibits the proliferation of A549 cells with an IC50 of 0.6 nM.
  • Inquiry Price
Size
QTY
BRM/BRG1 ATP Inhibitor-2
T600322368900-77-8
BRM BRG1 ATP Inhibitor-2 is a BRG1 BRM ATPase inhibitor, suitable for studies on the treatment of BAF-related disorders.
  • Inquiry Price
Size
QTY
BRM/BRG1 ATP Inhibitor-3
T722572368901-31-7
BRM BRG1 ATP Inhibitor-3 is a potent inhibitor targeting both BRM and BRG1 components of the BAF complex, with IC50 values of 10.4 nM for BRM and 19.3 nM for BRG1, and holds potential for research in cancer and BAF complex-related disorders.
  • Inquiry Price
6-8 weeks
Size
QTY
BRM/BRG1 ATP Inhibitor-4
T722582422030-94-0
BRM BRG1 ATP Inhibitor-4, a potent inhibitor of BRG1 BRM, is utilized in the research of cancers and BAF complex-related disorders.
  • Inquiry Price
6-8 weeks
Size
QTY
SMARCA2-IN-6
T2003602270875-79-9
SMARCA2-IN-6 is a potent inhibitor of SMARCA2 (also known as BRM), exhibiting an IC50 of less than 5 nM against both SMARCA2 and SMARCA4. Additionally, this compound suppresses the expression of the KRT80 gene in H1299 cells with an IC50 of 26 nM and inhibits the proliferation of SKMEL5 cells carrying a BRG1 mutation with an IC50 value of 13 nM.
  • Inquiry Price
8-10 weeks
Size
QTY
JQ dS-4
T2013782688882-69-9
JQ dS-4 is a degrader of Brahma-related gene 1 (BRG1) BRM SMARCA4 (PROTAC®; DC50 range = 9 - 390 nM in glioma models and cell lines), featuring a BRG1 inhibitor connected through a linker to a cereblon (CRBN) E3 ligase ligand. It effectively degrades BRG1 completely over 48 and 72 hours in HSJD-DIPG007 and SU-DIPGXIIIP cells. Additionally, it lessens the viability of various cancer cell lines, including those of H3K27M glioma, prostate, thyroid, and salivary gland.
  • Inquiry Price
Size
QTY
E3 Ligase Ligand-linker Conjugate 126
T201483
E3 Ligase Ligand-linker Conjugate 126 is an E3 ligase ligand-linker conjugate designed for the synthesis of PROTACs, such as PROTAC BRM BRG1 degrader-1.
  • Inquiry Price
Size
QTY
PROTAC SMARCA2 degrader-29
T2015412865193-25-3
PROTAC SMARCA2 degrader-29 (Example 87) is a potent PROTAC SMARCA2 (BRM) degrading agent with a DC50 ranging between 10-100 nM (BRM) and over 1 μM (BRG1, also known as SMARCA2).
  • Inquiry Price
Size
QTY
trans-(S,R,S)-AHPC-Me-Amide-cyclohexane-pyrimidine-Cl
T201567
trans-(S,R,S)-AHPC-Me-Amide-cyclohexane-pyrimidine-Cl is an E3 ligase ligand-Linker conjugate that is utilized in the synthesis of PROTACs, such as PROTAC BRM BRG1 degrader-2.
  • Inquiry Price
Size
QTY
E3 ligase Ligand 36
T2018503031995-12-4
E3 ligase Ligand 36 is an E3 ligase ligand that can be utilized for synthesizing PROTACs, such as PROTAC BRM BRG1 degrader-1.
  • Inquiry Price
Size
QTY
FHT-1204
T636862468048-24-8
FHT-1204 is a potent inhibitor of SMARCA4 SMARCA2 ATPase (BRG1 and BRM) (IC50 ≤ 10 nM).
  • Inquiry Price
8-10 weeks
Size
QTY
FHT-1015
FHT 1015, FHT1015
T639252368903-18-6
FHT-1015 is a potent SMARCA4 SMARCA2 ATPase (BRG1 and BRM) inhibitor with potential anticancer activity for the study of cancer and inflammation.
  • Inquiry Price
8-10 weeks
Size
QTY
IV-275
T79642
IV-275 is a dual inhibitor targeting the bromodomains of both BRG1 and BRM. This compound not only augments DNA damage when combined with Temozolomide and Bleomycin but also suppresses the invasiveness of GBM cells. Furthermore, IV-275 amplifies Temozolomide-induced cell death and its apoptosis-inducing activity [1].
  • Inquiry Price
Size
QTY
PROTAC BRM degrader-1
T872612378051-80-8
PROTAC BRM degrader-1 (compound 17) serves as a PROTAC-based degrader targeting both BRM and BRG1, exhibiting DC50 values of 93 pM and 4.9 nM, respectively [1].
  • Inquiry Price
Inquiry
Size
QTY
SMARCA2-IN-7
T888642270879-43-9
SMARCA2-IN-7 (compound 12) acts as a dual inhibitor for both BRM and BRG1 with IC50 values less than 0.005, exhibiting antitumor proliferation effects. It inhibits tumor proliferation in SKMEL5 cells lacking BRG1 with an AAC50 of 13 nM. Additionally, in H1299 cells, it suppresses cell proliferation activity of KRT880 with an AAC50 of 42 nM.
  • Inquiry Price
10-14 weeks
Size
QTY
SMARCA2-IN-8
T890512270875-93-7
SMARCA2-IN-8 (Compound 13) is an orally effective inhibitor targeting the SWI SNF chromatin remodeling complexes SMARCA2 (also known as Brahma homolog, BRM) and SMARCA4 (also known as Brahma-related gene 1, BRG1), with IC50 values of 5 nM and 6 nM respectively. This compound inhibits the proliferation of SMARCA2-mutant SKMEL5 cancer cells with an AAC50 of 5 nM and downregulates the expression of the SMARCA2-dependent gene KRT80, showing an AAC50 of 10 nM. Additionally, SMARCA2-IN-8 demonstrates antitumor efficacy and favorable pharmacokinetic properties in mice.
  • Inquiry Price
8-10 weeks
Size
QTY
FHD-286
T97492671128-05-3
FHD-286 is an inhibitor of BRM BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale